scholarly article | Q13442814 |
P356 | DOI | 10.3904/KJIM.2003.18.3.154 |
P953 | full work available at URL | https://doi.org/10.3904/kjim.2003.18.3.154 |
https://europepmc.org/articles/PMC4531625 | ||
https://europepmc.org/articles/PMC4531625?pdf=render | ||
http://www.kjim.org/upload/kjim-18-3-154-4.pdf | ||
P932 | PMC publication ID | 4531625 |
P698 | PubMed publication ID | 14619384 |
P5875 | ResearchGate publication ID | 9008087 |
P2093 | author name string | Won Kim | |
Myung Ho Jeong | |||
Soon Pal Suh | |||
Sang Rok Lee | |||
Jeong Gwan Cho | |||
Jong Chun Park | |||
Jung Chaee Kang | |||
Kye Hun Kim | |||
Joo Han Kim | |||
Byoung Hee Ahn | |||
Jae Young Rhew | |||
Ju Hyup Yum | |||
Ok Young Park | |||
Sang Hyung Kim | |||
Woo Kon Jeong | |||
Youn Keun Ahn | |||
P2860 | cites work | Atherosclerosis — An Inflammatory Disease | Q26776972 |
High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease | Q28181305 | ||
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men | Q29619308 | ||
Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology | Q33740111 | ||
Chlamydia pneumoniae, monocyte activation, and azithromycin in coronary heart disease | Q33762172 | ||
Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group | Q34064191 | ||
Decreased neointimal formation in Mac-1(-/-) mice reveals a role for inflammation in vascular repair after angioplasty | Q37175241 | ||
Role of new technology in balloon angioplasty | Q37547440 | ||
Treatment of Chlamydia pneumoniae infection with roxithromycin and effect on neointima proliferation after coronary stent placement (ISAR-3): a randomised, double-blind, placebo-controlled trial | Q37873906 | ||
Cytomegalovirus seropositivity and C-reactive protein have independent and combined predictive value for mortality in patients with angiographically demonstrated coronary artery disease | Q37875480 | ||
Prior cytomegalovirus, Chlamydia pneumoniae or Helicobacter pylori infection and the risk of restenosis after percutaneous transluminal coronary angioplasty | Q37876537 | ||
Treatment with the antibiotic roxithromycin in patients with acute non-Q-wave coronary syndromes. The final report of the ROXIS Study | Q37878753 | ||
C-Reactive protein and coronary artery disease: additional evidence of the implication of an inflammatory process in acute coronary syndromes | Q37879244 | ||
Evaluation of C-reactive protein, an inflammatory marker, and infectious serology as risk factors for coronary artery disease and myocardial infarction | Q37880581 | ||
Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction | Q37882420 | ||
Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction | Q37899465 | ||
C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study | Q40828366 | ||
Mechanisms and prevention of restenosis: from experimental models to clinical practice | Q41076451 | ||
Previous cytomegalovirus or Chlamydia pneumoniae infection and risk of restenosis after percutaneous transluminal coronary angioplasty | Q43429547 | ||
The restenosis paradigm revisited: an alternative proposal for cellular mechanisms | Q46465948 | ||
C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. Thrombolysis in Myocardial Infarction | Q47974191 | ||
Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators. | Q50866439 | ||
The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. | Q53824140 | ||
Novel inflammatory markers of coronary risk: theory versus practice. | Q54332281 | ||
The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable Angina | Q58230388 | ||
Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy | Q71210092 | ||
Identification of a potential role for the adventitia in vascular lesion formation after balloon overstretch injury of porcine coronary arteries | Q71792495 | ||
Potential role of human cytomegalovirus and p53 interaction in coronary restenosis | Q72041267 | ||
Inflammation and coronary artery disease | Q72071558 | ||
Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology | Q72708405 | ||
Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease | Q73088403 | ||
Interleukin-10 inhibits intimal hyperplasia after angioplasty or stent implantation in hypercholesterolemic rabbits | Q73492546 | ||
Inhibition of tissue factor-mediated coagulation markedly attenuates stenosis after balloon-induced arterial injury in minipigs | Q73558502 | ||
Predictive factors for the second restenosis after coronary interventions | Q73804283 | ||
Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease | Q73994849 | ||
High anti-cytomegalovirus (CMV) IgG antibody titer is associated with coronary artery disease and may predict post-coronary balloon angioplasty restenosis | Q74471681 | ||
Prior cytomegalovirus infection and the risk of restenosis after percutaneous transluminal coronary balloon angioplasty | Q74605700 | ||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | coronary balloon angioplasty | Q67272498 |
P304 | page(s) | 154-160 | |
P577 | publication date | 2003-09-01 | |
P1433 | published in | The Korean journal of internal medicine | Q26842387 |
P1476 | title | An elevated value of C-reactive protein is the only predictive factor of restenosis after percutaneous coronary intervention | |
An Elevated Value of C-Reactive Protein is the Only Predictive Factor of Restenosis after Percutaneous Coronary Intervention | |||
P478 | volume | 18 |